Bay Harbor Wealth Management, LLC Halozyme Therapeutics, Inc. Transaction History

Bay Harbor Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$32.86 - $55.7 $1,610 - $2,729	49 New	49 $1,000
Q1 2021 May 05, 2021	SELL	$39.51 - $51.45 $47,293 - $61,585	-1,197 Closed	0 $0
Q2 2019 Jul 18, 2019	SELL	$14.75 - $17.26 $4,469 - $5,229	-303 Reduced 20.2%	1,197 $21,000
Q4 2018 Feb 14, 2019	BUY	$13.33 - $18.66 $19,995 - $27,990	1,500 New	1,500 $22,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Bay Harbor Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bay Harbor Wealth Management, LLC with notifications on news.